Infusion Pump Market Report Size Analysis:

The infusion pump market size was valued at USD 13.12 billion in 2024 and is expected to reach USD 23.13 billion by 2032, growing at a CAGR of 7.32% over the forecast period of 2025-2032.

The infusion pump market is witnessing strong growth due to the growing incidence of chronic ailments such as diabetes, cancer, and pain disorders. Growing demand for home infusion care, advancements in smart pumps, and favorable regulatory approvals are also fueling market growth. The trend toward ambulatory and portable products increases patient comfort and adherence. Rising healthcare infrastructure developments and increasing emerging markets are leading to consistent global demand, driving the infusion pump market for further growth.

The U.S. infusion pump market size was valued at USD 4.52 billion in 2024 and is expected to reach USD 7.95 billion by 2032, growing at a CAGR of 7.30% over the forecast period of 2025-2032. The U.S. is in a leading position in the North American infusion pump market, and it commands a high percentage of the market revenue of the region. The country's dominance is due to reasons such as the high incidence of chronic diseases, high healthcare spending, well-developed medical infrastructure, and established infusion pump companies based in the nation. These factors together combine to contribute to the U.S.'s leadership in propelling the development and the North American infusion pump market growth.

For instance, In August 2023, ICU Medical, Inc., the medical device innovator with a global presence, declared that it had achieved 510(k) clearance from the United States Food and Drug Administration (FDA) for its Plum Duo infusion pump with embedded LifeShield infusion safety software. The Plum Duo pump, along with its safety software, will become available to customers in the U.S. during early 2024.

Infusion Pump Market Dynamics:

Drivers

• Hospital Admission and Surgery Rates Increase are Driving the Market Growth

Infusion pumps are essential equipment in hospitals, particularly during surgeries, intensive care, and emergency treatments. With increased hospitalization rates globally due to chronic diseases, trauma, and surgical interventions, the need for accurate and consistent drug delivery systems has increased significantly. Infusion pumps assist in delivering fluids, anesthesia, blood products, and medications in regulated dosages, which is particularly important during and after surgical procedures. As healthcare facilities deal with increasing volumes of patients, the demand for sophisticated infusion systems in hospitals is on the rise.

• Increasing Home Healthcare Trend is Propelling the Market Growth

There is a significant trend towards home-based care, fueled by the demand for affordable treatment, patient comfort, and the development of portable medical devices. Home infusion pumps are compact, user-friendly, and enable patients to receive therapies such as insulin infusion, pain management, and chemotherapy without the need to go to a hospital.

For Instance, as estimated by the U.S. Census Bureau, in 2030, all members of the baby boomer generation will be aged 65 and above, making up 21% of the population compared to 16% in 2016. The 65-and-older age group is expected to be around 73 million by then. Going even further into the future, the aged population will increase to 80 million by 2050, with persons aged 65 and above (77 million) outnumbering children under 18 (76.5 million).

This is especially beneficial for old patients or patients with chronic illnesses that require treatment over the long term. Expansion of telemedicine services and facilitating insurance policies also increases the utilization of infusion pumps in homecare environments.

Restraint

• High Cost of Infusion Pump Devices and Maintenance is Restraining the Infusion Pump Market Trends

Sophisticated infusion pumps, especially smart pumps with warning alerts and connectivity, are expensive. The cost incurs not just the upfront cost but also regular maintenance, calibration, patches to the software, and employee training. It is a drawback to small hospitals and clinics, as well as to low- and middle-income countries.

Infusion Pump Market Segmentation Analysis:

By Type

In 2024, the insulin pumps segment dominated the global infusion pump market share with around 36.80%, driven mainly by the rising burden of diabetes and the growing use of sophisticated insulin delivery systems. Insulin pumps have numerous benefits over classic multiple daily injections, such as more accurate insulin dosing, enhanced glycemic control, and improved quality of life for patients. The convergence of insulin pumps with continuous glucose monitoring (CGM) systems has also evolved diabetes management, where real-time adjustments are made and improved disease control is ensured.

For Instance, in August 2023, the FDA approved the Accu-Chek Solo micropump system, which consists of a tubeless insulin pump and a wireless handheld controller with Bluetooth. The controller is paired with blood glucose monitoring and gives bolus dosing recommendations.

The segment of insulin pumps is expected to grow at the fastest rate in the infusion pump market. This anticipated growth is driven by continued innovation in pump technology, such as the development of hybrid closed-loop systems that are capable of automating insulin delivery based on real-time glucose levels. In addition, increasing interest in personalized medicine and demand for home-based diabetes management solutions are also expected to continue driving the use of insulin pumps. With the healthcare systems around the globe concentrating on improved patient outcomes and effective treatments, insulin pumps are bound to play a deciding role in the future of diabetes care.

By Application

In 2024, the Diabetes segment led the infusion pump market with a market share of 52.14%, driven by increasing cases of diabetes and increased application of advanced insulin delivery systems.

According to the International Diabetes Federation estimates, in the year 2021, an estimated 537 million adults aged 20–79 years suffered from diabetes; by the year 2045, that number is estimated to rise to 783 million.

This spurt highlights the increased need for efficacious diabetes control solutions, leading to the prominence of the diabetes application segment within the infusion pump market. The diabetes application segment is anticipated to witness the fastest growth within the infusion pump market. Contributing factors to this projected growth are technology advances such as the merging of insulin pumps with continuous glucose monitoring (CGM) systems, closed-loop hybrid system development, and growing access to reimbursement policies favoring the use of such devices. These technologies improve the accuracy and ease of insulin delivery, making them more desirable to patients and medical professionals alike.

By End User

The hospitals segment dominated the infusion pump market with a 48.15% market share in 2024, mainly due to the sheer volume of medical treatments and procedures calling for accurate medication and fluid delivery. Infusion pumps are most consumed by Hospitals, which make up the most significant share in their usage since they are utilized in caring for critical care patients, such as those with cancer, diabetes, and other diseases. The hospitals' demand for infusion pumps is further driven by the need for various types of pumps, such as volumetric, syringe, and PCA pumps, to accommodate a range of therapies from anesthesia to pain management. Hospitals increasingly implement advanced features on smart infusion systems, including increased accuracy and patient safety, solidifying their position as market leaders.

The home care settings segment will exhibit the fastest growth in the forecast period with a 7.89% CAGR, due to the rising need for home-based healthcare service options. The expanding elderly population, rising incidence of chronic diseases such as diabetes, and the evolution of portable and user-friendly infusion technology are key factors driving this trend. Homecare environments provide patients with more comfort, convenience, and autonomy to control their treatment, particularly in diseases involving long-term infusion therapy, such as diabetes and pain management.

For instance, the need for home healthcare is increasing much more rapidly than the supply of available caregivers, creating a chronic workforce shortage. The home care workforce will need to grow by 34% from 2019 to 2029 to meet the increasing demand, as projected by the U.S. Bureau of Labor Statistics.

Regional Analysis:

North America dominated the infusion pump market with approximately 38.12% market share in 2024 due to its developed healthcare infrastructure, high healthcare expenditure, and early adoption of advanced medical technologies. The region houses some of the top players of the market, such as BD, Baxter, Medtronic, and ICU Medical, which invest heavily in innovation and product development.

In March 2022, healthcare technology global leader Medtronic plc launched in the U.S. its Medtronic Extended infusion set—the first and only infusion set indicated for up to 7-day wear. Infusion sets have historically been replaced every two or three days, as they transfer insulin from the pump to the body. This innovation is now available exclusively to users of the MiniMed 600 and 700 series insulin pumps.

Additionally, the pervasive prevalence of chronic diseases such as diabetes and cancer, coupled with increasing aging populations, spurs recurrent demand for infusion therapies. Facilitative regulatory environments, such as recurrent FDA approvals, also contribute to infusion pump market analysis and grant instant access to more recent devices.

Asia Pacific is the fastest-growing region in the infusion pump market with a 7.98% CAGR over the forecast period, driven by quick advancements in healthcare infrastructure, rising awareness of managing chronic diseases, and growth in a middle-class population with better access to medical services. China, India, and Japan are experiencing a boom in hospital investment and home healthcare services, driving the demand for portable and sophisticated infusion devices. Additionally, positive government policies towards increasing healthcare access and the increasing disease burden of conditions such as diabetes are driving adoption rates, making Asia Pacific a growth driver for the global market.

Europe is a leading player in the global infusion pump market, with its highly developed healthcare infrastructure, aging population, and high incidence of chronic diseases such as diabetes and cancer. Germany, the UK, and France are among the key contributors to market growth due to their strong healthcare systems and rising focus on patient-centered care.

Germany dominates the infusion pumps market in Europe owing to its developed healthcare system, the strong dominance of large players such as B. Braun Melsungen AG and Fresenius Kabi, and the uncontrolled demand for accurate medical technology. The chronic disease management emphasis of the country, including cancers and diabetes, results in frequent consumption of infusion therapy products.

Latin America exhibits moderate growth in the infusion pump market due to a growing incidence of chronic diseases such as diabetes and cancer, and an aging population. Brazil, Mexico, and Argentina are leading the development of healthcare infrastructure and the uptake of infusion technologies, especially in homecare and outpatient environments.

The Middle East & Africa region is also experiencing consistent growth as access to healthcare continues to improve and demand for sophisticated medical devices increases. The UAE, Saudi Arabia, and Egypt are investing in upgrading their healthcare infrastructures and adopting portable and intelligent infusion solutions. However, exorbitant device prices and compliance issues in less developed regions could moderate overall market development.

Infusion Pump Market Key Players

The infusion pump market companies include Becton, Dickinson and Company (BD), Baxter International Inc., Medtronic plc, Fresenius Kabi, ICU Medical, Inc., Smiths Medical, Terumo Corporation, Moog Inc., Nipro Corporation, Zyno Medical LLC, and other players.

Recent Developments in the Infusion Pump Market

• July 21, 2023 – BD (Becton, Dickinson and Company), a medical technology global leader, has announced that its new BD Alaris Infusion System received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The clearance will aid remediation and the full commercial reintroduction of the most extensive infusion system available in the United States.

• April 2024 – Baxter International Inc., a global leader in infusion therapies and technologies, has announced that it has received FDA 510(k) clearance for its Novum IQ Large Volume Infusion Pump (LVP) combined with Dose IQ Safety Software to support the safety and efficiency of infusion therapy delivery in the clinical environment.